Ning Dan, Garg Kunal, Mayer Benjamin, Schick Benedikt, Bracht Hendrik, Barth Eberhard, Weiss Manfred, Li Chen, Schneider Julian, Schneider E Marion
Clinic for Anaesthesiology and Intensive Care Medicine, Ulm University Hospital, Ulm, Germany.
Faculty of Medicine, Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
Front Med (Lausanne). 2023 Jan 5;9:1026298. doi: 10.3389/fmed.2022.1026298. eCollection 2022.
Sepsis causes a high rate of mortality and long-term morbidity, associated with an imbalance of innate immunity against infections and inflammation. Obesity and diabetes increase the risk for disease severity. Monocyte dysfunction plays a major role and justify further investigations.
To investigate the distribution and inflammatory phenotypes in circulating monocyte subsets in patients manifesting with sepsis including septic shock with and without obesity and diabetes.
A total of 235 blood samples were tested from critically ill adult patients registered at the intensive care unit (ICU). The cohorts were divided into non-diabetic groups with or without obesity and diabetic groups with or without obesity, suffering from sepsis or septic shock. We determined frequencies of total monocytes and of monocyte subsets in the circulation and density expression levels of functional markers, including CD14, CD16, HLA-DR, CD33, CD163, CD206, and arginase-1 by flow cytometric analysis.
When progressing to septic shock in non-diabetic and diabetic patients, the percentages of total monocytes among the leukocyte population and of CD33+ and CD14+ monocytes among the monocyte population were consistently down-regulated compared to non-sepsis in non-diabetic and diabetic patients, respectively. Non-diabetic sepsis patients further presented with decreased CD33 and up-regulated CD163 expression density, which was absent in diabetic patients. We subsequently addressed obesity-related changes of monocytes in non-diabetic and diabetic septic patients. Obese septic patients with diabetes were unique in displaying increased monocytic CD16 and CD163 expression. However, obese septic patients without diabetes solely presented with lower amounts of non-classical monocytes. Body mass index (BMI) dependent changes were restricted to diabetic septic patients, with a significantly higher diminution of the classical monocyte subset and concomitantly increased CD16 expression densities.
Distribution and phenotypes of monocyte subsets were differentially modulated in critically ill patients with and without metabolic disease when progressing to sepsis or septic shock. Only diabetic septic patients displayed decline of classical monocytes and increase of CD16 expression densities. Therefore, diabetes but not obesity appears to promote the inflammatory phenotype of circulating monocytes in critically ill patients.
脓毒症导致高死亡率和长期发病率,与针对感染和炎症的固有免疫失衡相关。肥胖和糖尿病会增加疾病严重程度的风险。单核细胞功能障碍起主要作用,值得进一步研究。
研究脓毒症患者(包括伴有或不伴有肥胖和糖尿病的脓毒性休克患者)循环单核细胞亚群的分布和炎症表型。
对重症监护病房(ICU)登记的成年重症患者的235份血样进行检测。这些队列被分为有或无肥胖的非糖尿病组以及有或无肥胖的糖尿病组,患有脓毒症或脓毒性休克。我们通过流式细胞术分析确定了循环中总单核细胞和单核细胞亚群的频率以及功能标志物(包括CD14、CD16、HLA-DR、CD33、CD163、CD206和精氨酸酶-1)的密度表达水平。
在非糖尿病和糖尿病患者进展为脓毒性休克时,与非脓毒症的非糖尿病和糖尿病患者相比,白细胞群体中总单核细胞的百分比以及单核细胞群体中CD33+和CD14+单核细胞的百分比分别持续下调。非糖尿病脓毒症患者进一步表现为CD33降低和CD163表达密度上调,而糖尿病患者则没有这种情况。我们随后研究了非糖尿病和糖尿病脓毒症患者中与肥胖相关的单核细胞变化。患有糖尿病的肥胖脓毒症患者在单核细胞CD16和CD163表达增加方面具有独特性。然而,不患有糖尿病的肥胖脓毒症患者仅表现为非经典单核细胞数量减少。体重指数(BMI)相关变化仅限于糖尿病脓毒症患者,经典单核细胞亚群的减少明显更高,同时CD16表达密度增加。
在进展为脓毒症或脓毒性休克时,患有和未患有代谢疾病的重症患者中单核细胞亚群的分布和表型受到不同调节。只有糖尿病脓毒症患者表现出经典单核细胞减少和CD16表达密度增加。因此,在重症患者中,似乎是糖尿病而非肥胖促进了循环单核细胞的炎症表型。